U.S. researchers looked at data from the Women's Health Initiative involving almost 60,000 white women and found that those who took aspirin regularly were 21% less likely to develop melanoma than nonusers. The longer aspirin was used, the lower their risk, according to the study in the journal Cancer. The reduced risk could be attributed to the anti-inflammatory properties of aspirin, lead author Dr. Jean Tang said.

Related Summaries